Results 31 to 40 of about 70,987 (344)
Plasmacytoid urothelial carcinoma of the bladder
Indian Journal of Pathology and Microbiology, 2014 Plasmacytoid urothelial carcinoma (PUC) of the urinary bladder is an uncommon and aggressive variant of urothelial carcinoma associated with late presentation and poor prognosis. Immunohistochemical examination showing expression of epithelial markers, CD138, and losing the membranous expression of E-cadherin confirms evidence of PUC. Here, we report a
Meihua Qin +3 more
openaire +3 more sources
Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. [PDF]
, 2012 BackgroundWe previously developed a bladder cancer-specific ligand (PLZ4) that can specifically bind to both human and dog bladder cancer cells in vitro and in vivo. We have also developed a micelle nanocarrier drug-delivery system.
de Vere White, Ralph +8 more
core +2 more sources
Urothelial Carcinoma of the Bladder: Radiologic Perspective
Journal of the Korean Society of Radiology, 2021 Bladder cancer is a relatively common cancer type, with a high recurrence rate, that can be often encountered in the imaging study. Accurate diagnosis and staging have a significant impact on determining treatment and evaluating prognosis. Bladder cancer has been evaluated by transurethral resection of bladder tumor for clinical staging and treatment ...
Dong Won Kim +2 more
openaire +2 more sources
Urological Science, 2016 Bladder diverticulum is an outpouching of bladder mucosa through the musculature of the bladder wall. The incidence of bladder diverticulum in Taiwan is about 1.7% in children and 23.4% in adults.
Hung-En Chen, Yi-Chia Lin, Yi-Hong Cheng
doaj +1 more source
The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma. [PDF]
, 2019 Bladder cancer is one of the most common cancers in the United States, but few advancements in treatment options have occurred in the past few decades.
Chang, Eric Y +7 more
core +1 more source
Sonographic Features of Urothelial Carcinoma: A Case Study [PDF]
Advanced Ultrasound in Diagnosis and Therapy, 2021 The most common type of bladder cancer is urothelial carcinoma which arises from the inside lining (e.g., urothelium) of the bladder. As the disease progresses, the tumor may invade into the deep layer of the bladder wall, spread to adjacent areas of the
Chelsea Robb. BS, RDMS, RVT, Traci Fox, EdD, RT(R), RDMS, RVT
doaj +1 more source
Bladder cancer pathology: from cystoscope to microscope [PDF]
, 2015 Pathologic evaluation of urinary bladder biopsies is considered as ‘gold standard’ for the diagnosis of urothelial lesions. Several pathologic entities, such as papillary cystitis, may mimick urothelial carcinoma.
Leenders, G.J.H.L. (Geert)
core +2 more sources
Giant Cell Urothelial Carcinoma of Bladder
Case Reports in Urology, 2021 Giant cell urothelial carcinoma is a rare variant of bladder cancer recognized by the current World Health Organization classification of urologic tumours. It is an aggressive tumour with a poor prognosis that usually presents at an advanced stage. It is characterized histologically by pleomorphic giant cells. We discuss a case of giant cell urothelial
Harshima Disvini Wijesinghe +1 more
openaire +3 more sources
Association between Age and Histopathological Grade of Bladder Urothelial Carcinoma
Althea Medical Journal, 2017 Background: Bladder cancer, particularly urothelial carcinoma, is prevalent in male and ≥55 years old population. Grade of the bladder tumor affects clinical characteristics, management, and prognosis of the patient.
Dionisius Alby +2 more
doaj +1 more source
BcCluster: a bladder cancer database at the molecular level [PDF]
, 2016 Background: Bladder Cancer (BC) has two clearly distinct phenotypes. Non-muscle invasive BC has good prognosis and is treated with tumor resection and intravesical therapy whereas muscle invasive BC has poor prognosis and requires usually systemic ...
Bhat, Akshay +5 more
core +3 more sources